These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8151322

  • 1. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.
    Johnson PW, Price CG, Smith T, Cotter FE, Meerabux J, Rohatiner AZ, Young BD, Lister TA.
    J Clin Oncol; 1994 Apr; 12(4):798-805. PubMed ID: 8151322
    [Abstract] [Full Text] [Related]

  • 2. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment.
    Pappa VI, Wilkes S, Salam A, Young BD, Lister TA, Rohatiner AZ.
    Bone Marrow Transplant; 1998 Sep; 22(6):553-8. PubMed ID: 9758342
    [Abstract] [Full Text] [Related]

  • 3. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.
    Rohatiner AZ, Johnson PW, Price CG, Arnott SJ, Amess JA, Norton AJ, Dorey E, Adams K, Whelan JS, Matthews J.
    J Clin Oncol; 1994 Jun; 12(6):1177-84. PubMed ID: 8201380
    [Abstract] [Full Text] [Related]

  • 4. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation.
    Hirt C, Dölken G.
    Bone Marrow Transplant; 2000 Feb; 25(4):419-26. PubMed ID: 10723586
    [Abstract] [Full Text] [Related]

  • 5. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T, Jedlicková K, Kriegová E, Jarosová M, Raida L, Faber E, Hubácek J, Vondráková J, Pikalová Z, Indrák K.
    Neoplasma; 2001 Feb; 48(6):501-5. PubMed ID: 11949845
    [Abstract] [Full Text] [Related]

  • 6. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
    Rohatiner AZ, Nadler L, Davies AJ, Apostolidis J, Neuberg D, Matthews J, Gribben JG, Mauch PM, Lister TA, Freedman AS.
    J Clin Oncol; 2007 Jun 20; 25(18):2554-9. PubMed ID: 17515573
    [Abstract] [Full Text] [Related]

  • 7. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations.
    Negrin RS, Pesando J.
    J Clin Oncol; 1994 May 20; 12(5):1021-7. PubMed ID: 8164025
    [Abstract] [Full Text] [Related]

  • 8. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.
    Apostolidis J, Gupta RK, Grenzelias D, Johnson PW, Pappa VI, Summers KE, Salam A, Adams K, Norton AJ, Amess JA, Matthews J, Bradburn M, Lister TA, Rohatiner AZ.
    J Clin Oncol; 2000 Feb 20; 18(3):527-36. PubMed ID: 10653868
    [Abstract] [Full Text] [Related]

  • 9. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma.
    Haas R, Moos M, Karcher A, Möhle R, Witt B, Goldschmidt H, Frühauf S, Flentje M, Wannenmacher M, Hunstein W.
    J Clin Oncol; 1994 Aug 20; 12(8):1685-92. PubMed ID: 7518860
    [Abstract] [Full Text] [Related]

  • 10. Myeloablative therapy with autologous bone marrow transplantation as consolidation of remission in patients with follicular lymphoma.
    Rohatiner AZ, Price CG, Arnott S, Norton A, Evans ML, Cotter F, Dorey E, Davis CL, Clark P, Sterlini J.
    Ann Oncol; 1991 Feb 20; 2 Suppl 2():147-50. PubMed ID: 2049312
    [Abstract] [Full Text] [Related]

  • 11. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
    Martin S, Fischer C, Free M, Kurreck B, Stockinger H, Fenk R, Arnold C, Kliszewski S, Meckenstock G, Haas R, Kronenwett R.
    Eur J Haematol; 2005 Apr 20; 74(4):282-92. PubMed ID: 15777339
    [Abstract] [Full Text] [Related]

  • 12. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma.
    Berinstein NL, Reis MD, Ngan BY, Sawka CA, Jamal HH, Kuzniar B.
    J Clin Oncol; 1993 Jul 20; 11(7):1344-52. PubMed ID: 8315432
    [Abstract] [Full Text] [Related]

  • 13. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P, Caulet-Maugendre S, Foussard C, Salles G, Moreau A, Rossi JF, Patey M, Rousselet MC, Bene MC, Damotte D, Cornillet Lefebvre P, Martin A, Costes V, GOELAMS group.
    Hum Pathol; 2008 Feb 20; 39(2):194-200. PubMed ID: 17949786
    [Abstract] [Full Text] [Related]

  • 14. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
    Ha CS, Tucker SL, Lee MS, McLaughlin P, Cabanillas F, Cox JD.
    Int J Radiat Oncol Biol Phys; 2001 Mar 01; 49(3):727-32. PubMed ID: 11172955
    [Abstract] [Full Text] [Related]

  • 15. Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
    Deggerdal AH, Pettersen F, Kvalheim G, Hornes E, Smeland E, Fodstad O, Hovig E.
    Lab Invest; 1995 Apr 01; 72(4):411-8. PubMed ID: 7723279
    [Abstract] [Full Text] [Related]

  • 16. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma.
    Rohatiner AZ, Freedman A, Nadler L, Lim J, Lister TA.
    Ann Oncol; 1994 Apr 01; 5 Suppl 2():143-6. PubMed ID: 8204513
    [Abstract] [Full Text] [Related]

  • 17. Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantation.
    Meijerink JP, Goverde GJ, Smetsers TF, Raemaekers JM, Bogman MJ, de Witte T, Mensink EJ.
    Ann Oncol; 1994 Apr 01; 5 Suppl 1():43-5. PubMed ID: 8172816
    [Abstract] [Full Text] [Related]

  • 18. Comparative preclinical study of three bone marrow purging methods using PCR evaluation of residual t(14;18) lymphoma cells.
    Yerly-Motta V, Racadot E, Fest T, Bastard C, Ferrand C, Deschaseaux ML, Herve P.
    Leuk Lymphoma; 1996 Oct 01; 23(3-4):313-21. PubMed ID: 9031112
    [Abstract] [Full Text] [Related]

  • 19. Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.
    Paszkiewicz-Kozik E, Kulik J, Fabisiewicz A, Tysarowski A, Kraszewska E, Siedlecki JA, Walewski J.
    Med Oncol; 2009 Oct 01; 26(1):16-21. PubMed ID: 18470485
    [Abstract] [Full Text] [Related]

  • 20. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.
    Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ.
    N Engl J Med; 1991 Nov 28; 325(22):1525-33. PubMed ID: 1944436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.